InvestorsHub Logo
Followers 87
Posts 6642
Boards Moderated 1
Alias Born 09/18/2009

Re: US-JUSTICE post# 42671

Wednesday, 06/19/2024 9:28:58 AM

Wednesday, June 19, 2024 9:28:58 AM

Post# of 42751
Management's Objection regarding claims on account of Equity Interest was not what I had hoped it would be. Here is a list of the claimants, in this regard, in case you haven't seen it.

start on pg 19/26
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1079544&projectCode=HUM&docketNumber=254&source=DM

I mention it because I did not see Cheryl Buxton's name on it. But the list I saw did mention John Hohneker and Kevin Xie. Now, I see none of the three.

https://www.streetinsider.com/Board+Changes/Humanigen+%28HGEN%29+Announces+Resignations+of+Three+Directors%2C+Company+Now+not+Compliant+with+Nasdaq+Rules/21941128.html

Maybe I need SG44's eyes on this, or maybe I need to finish my first cup of coffee. But I think there has to be another version of the list somewhere.

I just find it a little curious. I still believe that we will have a successful conclusion by the time additional information relative to the co-exclusive licensing deal between Sanofi and Novavax is made known.